VK4-116 Phase I Study With Food-Effect

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This first-in-human, randomized, double-blind, placebo-controlled, single ascending dose (SAD), phase I study is designed to assess the safety, tolerability and pharmacokinetics of VK4-116 in healthy volunteers in fasted and fed state.
Epistemonikos ID: 5ac14d01ec26acfb438c1ecf759683f262b14596
First added on: Mar 27, 2025